A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.




TekijätCho SH, Goenka S, Henttinen T, Gudapati P, Reinikainen A, Eischen CM, Lahesmaa R, Boothby M

Julkaisuvuosi2009

Lehti:Blood

Tietokannassa oleva lehden nimiBlood

Lehden akronyymiBlood

Vuosikerta113

Numero11

Aloitussivu2416

Lopetussivu25

Sivujen määrä-2390

ISSN1528-0020

DOIhttps://doi.org/10.1182/blood-2008-03-144121

Verkko-osoitehttp://www.bloodjournal.org/content/bloodjournal/113/11/2416.full.pdf


Tiivistelmä

Poly(ADP-ribos)ylation is one of the longest-known but most enigmatic posttranslational modifications transducing specific signals. The enzyme responsible for the majority of poly(ADP-ribose) polymerization in cells, PARP-1, promotes DNA repair but also mediates a caspase-independent form of apoptosis in response to stressors such as irradiation. However, the biologic function of most other PARPs is not known. Macro-PARPs constitute one branch of the large family of PARP-like proteins also designated as B aggressive lymphoma proteins (BAL1, 2a/2b, 3, or PARP-9, PARP-14, and PARP-15). To elucidate biologic role(s) of a BAL-family macro-PARP, we analyzed mice deficient in PARP-14, a binding partner of the IL-4-induced transcription factor Stat6. We show here that PARP-14 plays a fundamental role mediating protection against apoptosis in IL-4-treated B cells, including that after DNA damage, and mediates IL-4 effects on the levels of gene products that regulate cell survival, proliferation, and lymphomagenesis. Collectively, the results establish that PARP-14 mediates regulation of gene expression and lymphocyte physiology by IL-4 and has a function distinct from PARP-1. Furthermore, the findings suggest mechanisms by which BAL-family proteins might influence pathologic processes involving B lymphocytes.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-14-10 at 10:16